Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus ... joint robotic space. While the immediate impact of ExcelsiusFlex is downplayed in favor of focusing on the Spine segment ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

Globus Medical is gaining high-level synergy from the continuously increasing adoption of its ExcelsiusGPS robot and Excelsius3D imaging systems in spinal surgery. Additionally, the third quarter ...

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.